Fluxome-CEO: We want to be among the best in the world
Ambitions are sky-high in the Danish biotech company Fluxome, and the first European distribution deals are almost in place.
The biotech company Fluxome Sciences A/S, which is now launching a food supplement – the substance of which is known as the health-giving property of red wine – in Europe, expects to become one of the world’s strongest actors on a rapidly expanding market, says temporarily instated CEO Jarne Elleholm, who is also a partner in Vækstfonden.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
